{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:05:29Z","timestamp":1793232329893,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T00:00:00Z","timestamp":1497657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10096-017-3032-6","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T20:45:34Z","timestamp":1497645934000},"page":"2101-2107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0471-8250","authenticated-orcid":false,"given":"A.","family":"Post","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Martiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"van Waterschoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Maniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bottieau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Van Esbroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Vlieghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ombelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Vandenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,17]]},"reference":[{"issue":"3","key":"3032_CR1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/CMR.00006-15","volume":"28","author":"NO Kaakoush","year":"2015","unstructured":"Kaakoush NO, Castano-Rodriguez N, Mitchell HM, Man SM (2015) Global epidemiology of campylobacter infection. Clin Microbiol Rev 28(3):687\u2013720","journal-title":"Clin Microbiol Rev"},{"key":"3032_CR2","unstructured":"Antimicrobial Therapy Inc. (2012\u20132013) Sanford guide to antimicrobial therapy. Antimicrobial Therapy Inc., Sperryville VA"},{"key":"3032_CR3","first-page":"8","volume-title":"Optimaliseren van het antibioticabeleid in Nederland. Antibiotische therapie per verwekker","author":"SWAB","year":"2014","unstructured":"SWAB (2014) Optimaliseren van het antibioticabeleid in Nederland. Antibiotische therapie per verwekker. Stichting Werkgroep Antibiotica Beleid (SWAB), Nijmegen, p 8"},{"key":"3032_CR4","volume-title":"The global view of Campylobacteriosis: report of an expert consultation","author":"WHO","year":"2012","unstructured":"WHO (2012) The global view of Campylobacteriosis: report of an expert consultation. WHO, Utrecht"},{"issue":"1","key":"3032_CR5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2334-4-54","volume":"4","author":"K Ekdahl","year":"2004","unstructured":"Ekdahl K, Andersson Y (2004) Regional risks and seasonality in travel-associated campylobacteriosis. BMC Infect Dis 4(1):54","journal-title":"BMC Infect Dis"},{"issue":"8","key":"3032_CR6","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1093\/cid\/cir509","volume":"53","author":"B Feodoroff","year":"2011","unstructured":"Feodoroff B, Lauhio A, Ellstrom P, Rautelin H (2011) A nationwide study of campylobacter jejuni and campylobacter coli bacteremia in Finland over a 10-year period, 1998-2007, with special reference to clinical characteristics and antimicrobial susceptibility. Clin Infect Dis 53(8):e99\u2013e106","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3032_CR7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1708-8305.2008.00236.x","volume":"15","author":"ER Vlieghe","year":"2008","unstructured":"Vlieghe ER, Jacobs JA, Van Esbroeck M, Koole O, Van Gompel A (2008) Trends of norfloxacin and erythromycin resistance of campylobacter jejuni\/campylobacter coli isolates recovered from international travelers, 1994 to 2006. J Travel Med 15(6):419\u2013425","journal-title":"J Travel Med"},{"key":"3032_CR8","unstructured":"European Centre for Disease Prevention and Control (2014) EU protocol for harmonised monitoring of antimicrobial resistance in human Salmonella and Campylobacter isolates, Sweden, http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/AMR-salmonella-campylobacter-protocol-monitoring.pdf . Cited Accessed; 06\u201309-2015"},{"key":"3032_CR9","doi-asserted-by":"crossref","unstructured":"On SL (2001) Taxonomy of Campylobacter, Arcobacter, Helicobacter and related bacteria: current status, future prospects, and immediate concerns. Symposium series (Society for Applied Microbiology) 30:1s\u201315s","DOI":"10.1046\/j.1365-2672.2001.01349.x"},{"key":"3032_CR10","volume-title":"M100-S26 performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement","author":"CLSI","year":"2016","unstructured":"CLSI (2016)M100-S26 performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. CLSI, Wayne PA"},{"key":"3032_CR11","unstructured":"United Nations (2013) Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. UN Statistics Division"},{"key":"3032_CR12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijid.2015.11.005","volume":"42","author":"J Zhou","year":"2016","unstructured":"Zhou J, Zhang M, Yang W, Fang Y, Wang G, Hou F (2016) A seventeen-year observation of the antimicrobial susceptibility of clinical campylobacter jejuni and the molecular mechanisms of erythromycin-resistant isolates in Beijing, China. Int J Infect Dis 42:28\u201333","journal-title":"Int J Infect Dis"},{"issue":"2","key":"3032_CR13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1128\/AAC.49.2.699-707.2005","volume":"49","author":"DJ Griggs","year":"2005","unstructured":"Griggs DJ, Johnson MM, Frost JA, Humphrey T, Jorgensen F, Piddock LJ (2005) Incidence and mechanism of ciprofloxacin resistance in campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment. Antimicrob Agents Chemother 49(2):699\u2013707","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3032_CR14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4161\/viru.23753","volume":"4","author":"NM Iovine","year":"2013","unstructured":"Iovine NM (2013) Resistance mechanisms in campylobacter jejuni. Virulence 4(3):230\u2013240","journal-title":"Virulence"},{"key":"3032_CR15","first-page":"340605","volume":"2013","author":"K Wieczorek","year":"2013","unstructured":"Wieczorek K, Osek J (2013) Antimicrobial resistance mechanisms among campylobacter. Biomed Res Int 2013:340605","journal-title":"Biomed Res Int"},{"issue":"3","key":"3032_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1995-7645(14)60314-X","volume":"8","author":"FM Siddiqui","year":"2015","unstructured":"Siddiqui FM, Akram M, Noureen N, Noreen Z, Bokhari H (2015) Antibiotic susceptibility profiling and virulence potential of campylobacter jejuni isolates from different sources in Pakistan. Asian Pac J Trop Med 8(3):197\u2013202","journal-title":"Asian Pac J Trop Med"},{"issue":"1","key":"3032_CR17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3201\/eid0701.010104","volume":"7","author":"J Engberg","year":"2001","unstructured":"Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I (2001) Quinolone and macrolide resistance in campylobacter jejuni and C. Coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 7(1):24\u201334","journal-title":"Emerg Infect Dis"},{"key":"3032_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijfoodmicro.2014.03.003","volume":"178","author":"S Abay","year":"2014","unstructured":"Abay S, Kayman T, Otlu B, Hizlisoy H, Aydin F, Ertas N (2014) Genetic diversity and antibiotic resistance profiles of campylobacter jejuni isolates from poultry and humans in Turkey. Int J Food Microbiol 178:29\u201338","journal-title":"Int J Food Microbiol"},{"issue":"2","key":"3032_CR19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1179\/joc.2010.22.2.142","volume":"22","author":"A Mosca","year":"2010","unstructured":"Mosca A, Del Gaudio T, Miragliotta G (2010) Imipenem-resistant campylobacter fetus bloodstream infection. J Chemother 22(2):142","journal-title":"J Chemother"},{"key":"3032_CR20","unstructured":"WHO (2017) WHO priority pathogens list for R&D of new antibiotics. [Available from: http:\/\/www.who.int\/medicines\/publications\/global-priority-list-antibiotic-resistant-bacteria\/en\/ ]"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-017-3032-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-3032-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-3032-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T02:45:28Z","timestamp":1569465928000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-017-3032-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,17]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3032"],"URL":"https:\/\/doi.org\/10.1007\/s10096-017-3032-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,17]]}}}